Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations.
Saved in:
| Title: | Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations. |
|---|---|
| Authors: | Yengo CK; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Liu X; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Laghlali G; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Pharmaceutics, Ghent University, Ghent, Belgium., Park SC; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Klingler J; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Luo CC; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States., Jiang X; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States., Kong XP; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States., Rao PG; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Upadhyay C; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Wiest MJ; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.; Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States., Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., De Geest BG; Department of Pharmaceutics, Ghent University, Ghent, Belgium., Wong PT; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.; Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States.; Department of Biomedical Engineering, University of Michigan Medical School, Ann Arbor, MI, United States., Tam Y; Acuitas Therapeutics, Vancouver, BC, Canada., Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Schotsaert M; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Hioe CE; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Dec 08; Vol. 16, pp. 1722596. Date of Electronic Publication: 2025 Dec 08 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41438749 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yengo+CK%22">Yengo CK</searchLink>; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Laghlali+G%22">Laghlali G</searchLink>; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Pharmaceutics, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Park+SC%22">Park SC</searchLink>; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Klingler+J%22">Klingler J</searchLink>; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Luo+CC%22">Luo CC</searchLink>; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Jiang+X%22">Jiang X</searchLink>; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Kong+XP%22">Kong XP</searchLink>; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Rao+PG%22">Rao PG</searchLink>; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Upadhyay+C%22">Upadhyay C</searchLink>; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Wiest+MJ%22">Wiest MJ</searchLink>; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.; Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Muramatsu+H%22">Muramatsu H</searchLink>; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22De+Geest+BG%22">De Geest BG</searchLink>; Department of Pharmaceutics, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Wong+PT%22">Wong PT</searchLink>; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.; Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States.; Department of Biomedical Engineering, University of Michigan Medical School, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Tam+Y%22">Tam Y</searchLink>; Acuitas Therapeutics, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Pardi+N%22">Pardi N</searchLink>; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Schotsaert+M%22">Schotsaert M</searchLink>; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Hioe+CE%22">Hioe CE</searchLink>; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Dec 08; Vol. 16, pp. 1722596. <i>Date of Electronic Publication: </i>2025 Dec 08 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41438749 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1722596 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1722596 Titles: – TitleFull: Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yengo CK – PersonEntity: Name: NameFull: Liu X – PersonEntity: Name: NameFull: Laghlali G – PersonEntity: Name: NameFull: Park SC – PersonEntity: Name: NameFull: Klingler J – PersonEntity: Name: NameFull: Luo CC – PersonEntity: Name: NameFull: Jiang X – PersonEntity: Name: NameFull: Kong XP – PersonEntity: Name: NameFull: Rao PG – PersonEntity: Name: NameFull: Upadhyay C – PersonEntity: Name: NameFull: Wiest MJ – PersonEntity: Name: NameFull: Muramatsu H – PersonEntity: Name: NameFull: De Geest BG – PersonEntity: Name: NameFull: Wong PT – PersonEntity: Name: NameFull: Tam Y – PersonEntity: Name: NameFull: Pardi N – PersonEntity: Name: NameFull: Schotsaert M – PersonEntity: Name: NameFull: Hioe CE IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 12 Text: 2025 Dec 08 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |